A Study to Compare the Pharmacokinetics of Belatacept Using Active Pharmaceutical Ingredient Manufactured by Process E Relative to Process C
Clinical trial NCT02564497 · COMPLETED
Trial details
- NCT number
- NCT02564497
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-02
- Primary completion
- 2017-01-27
- Enrollment
- 491
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.